New Chinese patent approval for Episurf Medical
The Chinese patent office SIPO has announced that Episurf Medical (NASDAQ: EPIS B) has obtained another granted patent in China. The patent, entitled “Design method of a rig”, is within the area of individualised surgical instruments with a focus on the drill guide for the Episealer® Femoral Twin implant. "This patent gives an improved IP protection within Episurf Medical’s individualised drill guides, forming a crucial part of the company’s Episealer® technology”, comments Katarina Flodström, COO, Episurf Medical.